Influence of <i>TP53</i> Comutation on the Tumor Immune Microenvironment and Clinical Outcomes With Immune Checkpoint Inhibitors in <i>STK11</i>-Mutant Non–Small-Cell Lung Cancer
2024 · JCO Precision Oncology · 2 citations
https://doi.org/10.1200/po.23.00371